Sign in

CIK 0001737953

  • Non-accelerated filer
  • Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
822082553
Phone
+1 781-222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
  1. 4 Open-market sale Director sold 11,359 shares at an average $45.04 ($511,658)
  2. 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $43.76 ($2,187,790)
  3. 4 Open-market sale Chief Business Officer sold 55,000 shares at an average $43.99 ($2,419,344)
  4. 4 Open-market sale Chief Operating Officer sold 30,000 shares at an average $43.24 ($1,297,065)
  5. 4 Open-market sale Director sold 19,580 shares at an average $45.10 ($883,054)
  6. 4 Open-market sale Chief Financial Officer sold 15,000 shares at an average $44.53 ($667,884)
  7. 4 Open-market sale President & Chief R&D Officer sold 220,000 shares at $40.04 ($8,808,800)
  8. 4 Option exercise Chief Business Officer acquired 50,704 shares (option exercise)
  9. 4 Open-market sale Director sold 4,319 shares at $41.95 ($181,182)
  10. 4 Open-market sale Director sold 65,029 shares at an average $42.28 ($2,749,721)
  11. 4 Open-market sale Chief Financial Officer sold 25,000 shares at an average $43.45 ($1,086,200)
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 11 of 16 · 316 filings